Medos International SARL: FDA filings under this applicant name
FDA lists 101 510(k) clearances under 3 spellings of the applicant name “Medos International SARL” (first 2010, latest 2026), across 25 product codes in 4 review panels. Median 510(k) review time under this name: 90 days. Since 2017 the median was 90 days, against 92 days for all cleared 510(k)s in the same product codes. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 7 | 80 |
| 2013 | 3 | 42 |
| 2014 | 3 | 116 |
| 2015 | 4 | 127 |
| 2016 | 12 | 104 |
| 2017 | 8 | 73 |
| 2018 | 10 | 113 |
| 2019 | 12 | 104 |
| 2020 | 8 | 108 |
| 2021 | 6 | 70 |
| 2022 | 9 | 111 |
| 2023 | 8 | 88 |
| 2024 | 2 | 70 |
| 2025 | 2 | 60 |
| 2026 | 2 | 108 |
Review time against the same product codes
Since 2017, 510(k)s cleared under the name Medos International SARL took a median 90 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 92 days.
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| NKB | Thoracolumbosacral Pedicle Screw System | 16 | 16 |
| MAX | Intervertebral Fusion Device With Bone Graft, Lumbar | 12 | 12 |
| OLO | Orthopedic Stereotaxic Instrument | 12 | 12 |
| MBI | Fastener, Fixation, Nondegradable, Soft Tissue | 11 | 11 |
| MAI | Fastener, Fixation, Biodegradable, Soft Tissue | 8 | 8 |
| NKG | Posterior Cervical Screw System | 6 | 6 |
| GAT | Suture, Nonabsorbable, Synthetic, Polyethylene | 5 | 5 |
| JXG | Shunt, Central Nervous System And Components | 4 | 4 |
| KWQ | Appliance, Fixation, Spinal Intervertebral Body | 4 | 4 |
| HRX | Arthroscope | 3 | 3 |
Plus 15 more product codes.
Review panels
- Orthopedic (81)
- Neurology (11)
- General and Plastic Surgery (7)
- Cardiovascular (2)
Most recent Medos International SARL 510(k) clearances
| 510(k) | Device | Product code | Decision date | Review days |
|---|---|---|---|---|
| K254157 | CROSSNAV Navigation Enabled Instruments for Disc Preparation and Interbody | OLO | 2026-05-26 | 155 |
| K260240 | SYMPHONY Navigation Ready Instruments | OLO | 2026-03-27 | 60 |
| K253249 | TriALTIS Spine System | NKB | 2025-10-21 | 22 |
| K243249 | TriALTIS Spine System | NKB | 2025-01-17 | 98 |
| K241893 | CROSSNAV Navigation Enabled Instruments and UNAS Navigation Arrays | OLO | 2024-09-16 | 80 |
| K242042 | TriALTIS Spine System | NKB | 2024-09-09 | 59 |
| K233684 | TriALTIS Spine System | NKB | 2023-12-12 | 26 |
| K233366 | SYMPHONY OCT System | NKG | 2023-11-09 | 38 |
| K232492 | 2.7 mm GRYPHON Flex Knotless PEEK Anchor; 2.7 mm GRYPHON Flex Knotless Biocomposite Anchor | MBI | 2023-10-06 | 50 |
| K231527 | TriALTIS Navigation Enabled Instruments | OLO | 2023-09-29 | 126 |
91 earlier clearances. See the full list in Caduvo.
Recalls
2 product recalls in 2 recall events; 2 initiated in the last five years. Most recent: 2026-07-23.
24 product recalls in 10 recall events filed under other recalling-firm names cite a 510(k) or PMA held under this applicant name; 1 initiated in the last five years. Most often: Codman & Shurtleff, Inc. (16), Biomet, Inc. (2), DePuy Spine, Inc. (2).
These recall records list the clearance number, so the device was cleared under this name. The recalling firm may be the same company under another spelling, a company that acquired the product line, a relabeler or a contract manufacturer. They are not added to the count above.
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Device clinical trials
An industry sponsor named Medos International SARL is the lead sponsor of 2 device studies on ClinicalTrials.gov (0 active or recruiting). Most recent:
- NCT05316311: A Study of Implantation of CRENEOUS ENTERPRISE 2 Intracranial Stent in Participants With Severe Symptomatic Intracranial Atherosclerotic Stenosis (Completed, started 2022-05-24)
- NCT04289480: Safety and Effectiveness of ENTERPRISE 2 Device in the Endovascular Treatment of Intracranial Aneurysms (Completed, started 2020-07-30)
FDA spellings included
FDA records this applicant under 3 spellings (case, punctuation and legal-suffix variants of one name); this page adds them up. Filings per spelling:
- Medos International SARL (96)
- Medos International Sàrl (4)
- Medos-International Sarl (1)
Other FDA applicant names starting with the same word
FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.
- Medos Medizintechnik AG (3 510(k)s)
- Medos Sarl (1 510(k)s)
Frequently asked questions
How many FDA 510(k) clearances are listed under Medos International SARL?
FDA lists 101 510(k) clearances under 3 spellings of the applicant name “Medos International SARL” (first 2010, latest 2026), across 25 product codes in 4 review panels. Filings under other applicant names, such as subsidiaries, are not included.
How long has FDA taken to clear 510(k)s filed by Medos International SARL?
The median time from FDA receipt to decision across 510(k)s cleared under the name Medos International SARL is 90 days. Since 2017: 90 days, versus 92 days for all cleared 510(k)s in the same product codes.
Which FDA product codes appear under Medos International SARL?
The most frequent FDA product codes under this applicant name are NKB (Thoracolumbosacral Pedicle Screw System, 16); MAX (Intervertebral Fusion Device With Bone Graft, Lumbar, 12); OLO (Orthopedic Stereotaxic Instrument, 12).
Next steps
- See all 101 Medos International SARL clearances with predicates and recalls
- Run predicate analysis for product code NKB, Medos International SARL's most frequent
Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant names shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.